91³Ô¹Ï

ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
91³Ô¹Ï

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91³Ô¹Ï Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

91³Ô¹Ï Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 3330

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Comparative study of two antigens of Edwardsiella tarda as DNA vaccine candidates in Labeo rohita

6th World Congress on Biotechnology

Megha Kadam Bedekar, Ranjeeta Kumari and Makesh M

Central Institute of Fisheries Education, India

ScientificTracks Abstracts: J Biotechnol Biomater

DOI:

Abstract
Edwardsiella tarda is an important pathogen of fish globally. This pathogen is also important from a public health point of view, as this is known to produce disease in reptiles, birds, humans and other mammals. In spite of these facts, there is no established successful commercial treatment or preventive measure available. Labeo rohita which is not just an Indian major carp but is also an important part of Indian economy is one of the sufferers of Edwardsiellosis. There is a heavy quality loss in L. rohita because of this bacterial infection. Our laboratory is working on developing a DNA based vaccine against this pathogen. With this aim in present study we compared vaccine potential of two important antigens of Edwardsiella tarda as DNA construct in L. rohita fingerlings. L. rohita fingerlings were DNA immunized with recombinant glyceraldehyde-3- phosphate dehydrogenase (GAPDH) and Outer Membrane Protein (OMP-S) genes of E. tarda. PCR primers were designed for both the gene using NCBI GenBank sequences. Amplified genes were cloned in eukaryotic expression vector pIRES 6.5 and purified. Two different groups of L. rohita fingerlings were immunized with 10 �¼g of respective DNA construct followed by booster at 14 day post vaccination. At 35th day, both the groups were challenged pathogenic E. tarda culture available in our laboratory. Relative percentage survivability, antibody titre, cell mediated immune response and immune gene expression analysis was done. We recorded that RPS was significantly higher in GAPDH group (73%) compared to OMP-S group (62 %). Competitive ELISA test indicated higher antibody titre in OMP-S group than GAPDH group. However nonspecific indicators NBT and phagocytic assay were significantly higher in GAPDH group. iNOS, Il�²1 and IFN�³ gene which are key regulators of immune mechanism were significantly up regulated in GAPDH group compared to OMP-S group. Our study suggested that GAPDH gene can be an ideal candidate for DNA immunization against E. tarda in L. rohita. But the antibody response generated is higher if we use OMP-S.
Biography

Megha Kadam Bedekar is working as Senior Scientist in Aquatic Animal Health and Management division of ICAR, Central Institute of Fisheries Education, Deemed University located in Mumbai. She is working on developing vaccines against fish pathogens and also on characterizing the immune pathways of fish and shellfish. She is basically a Veterinary graduate, PhD in Animal Biotechnology from Indian Institute of Veterinary Research, India. She is also working as an Editor and Reviewer for many journals.

Email: meghakadambedekar@gmail.com

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top